Loading organizations...
§ Private Profile · Morrisville, NC, USA
Develops human tissue-based products for vascular disease and surgery.
Humacyte has raised $301.1M across 5 funding rounds.
Humacyte has raised $301.1M in total across 5 funding rounds.
Humacyte has raised $301.1M in total across 5 funding rounds.
Humacyte's investors include Scott McCarty, California Institute for Regenerative Medicine, Brady Dougan, Gavril Yushvaev, Access Industries, Bangkok Bank, Pacific Eagle Asset Management, Reignwood Group.
Humacyte has raised $301.1M across 5 funding rounds. Most recently, it raised $50.0M Debt in April 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 14, 2021 | $50M Debt Financing | Scott Mccarty | — | Announced |
| Mar 9, 2018 | $75M Series C | — | — | Announced |
| Sep 29, 2017 | $14.1M Grant | California Institute For Regenerative Medicine | — | Announced |
| Oct 20, 2015 | $150M Series B | — | Brady Dougan, Gavril Yushvaev, Access Industries, Bangkok Bank, Pacific Eagle Asset Management, Reignwood Group | Announced |
| Sep 8, 2010 | $12M Debt Financing | — | — | Announced |